Health Sciences Acquisitions Corporation 2
Health Sciences Acquisitions Corporation 2 (HSAQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hsaq · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Health Sciences Acquisitions Corporation 2 (HSAQ) measures how much investors pay for each dollar of the company's trailing earnings. HSAQ's current PE ratio of N/A is calculated by dividing its stock price of $13.31 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2020 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Health Sciences Acquisitions Corporation 2You HSAQ | $149M | N/A | — | -$0.00 |
 Aurora Acquisition Corp. AURC | $141M | N/A | — | -$10.80 |
 Blockchain Coinvestors Acquisition Corp. I BCSA | $149M | 31.06x | +10.5% | $0.35 |
 HPX Corp. HPX | $149M | N/A | — | -$0.22 |
 Landcadia Holdings IV, Inc. LCA | $143M | 20.73x | -26.2% | $0.48 |
 LAVA Medtech Acquisition Corp. LVAC | $150M | 32.52x | +15.7% | $0.31 |
 Cartesian Growth Corporation II RENE | $155M | N/A | — | -$0.23 |
Industry Average 3 peers with valid PE | — | 28.10x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.00 | — | |
2024-12-31 FY2024 | — | $-0.00 | — | |
2022-12-31 FY2022 | — | $-0.15 | — | |
2021-12-31 FY2021 | — | $-0.02 | — | |
2020-12-31 FY2020 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Health Sciences Acquisitions Corporation 2 (HSAQ) measures how much investors pay for each dollar of the company's trailing earnings. HSAQ's current PE ratio of N/A is calculated by dividing its stock price of $13.31 by its TTM earnings per share of -$0.00.
Frequently asked questions
HSAQ pe ratio · 6 questionsHSAQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $13.31 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via HSAQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Health Sciences Acquisitions Corporation 2 SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09